Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with proteasome inhibitor | Patent Number 08648095

US 08648095 B2
Application Number13488888
Publication NumberUS 20120244214 A1
Pendency1 year, 8 months, 11 days
Filled DateJun 5, 2012
Priority DateMay 17, 2002
Publication DateSep 27, 2012
Expiration DateMay 17, 2022
Inventor/ApplicantsJerome B. Zeldis
ExaminesSIMMONS, CHRIS E
Art Unit1629
Technology Center1600
Assignments
Celgene
Current
CelgeneBristol Myers Squibb
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.